Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 39

Sort by

Sort Order Select

Journal Articles

Pediatric T-cell lymphoblastic lymphomas but not leukemias harbor TRB :: NOTCH1 fusions with unfavorable outcome

Blood (2024) 144 (13): 1412–1417.

https://doi.org/10.1182/blood.2024025307

Published: 2024

Includes: Supplemental data

Journal Articles

Mutational and transcriptional landscape of pediatric B-cell precursor lymphoblastic lymphoma

Blood (2024) 144 (1): 74–83.

https://doi.org/10.1182/blood.2024023938

Published: 2024

Includes: Supplemental data

Journal Articles

A Phase I/II Trial to Evaluate the Safety, Pharmacokinetics, and Efficacy of Glofitamab As Monotherapy and in Combination with R-ICE Chemoimmunotherapy in Children and Young Adults with Relapsed/Refractory B-Cell Non-Hodgkin Lymphoma (iMATRIX-GLO)

Birgit Burkhardt, Gianluca Rossato, Mark Dixon, David John Carlile, Steven Dmytrasz, Jade Wulff, Raluca Negricea, Beate Wulff

Blood (2023) 142 (Supplement 1): 3096.

https://doi.org/10.1182/blood-2023-174929

Published: 2023

Journal Articles

EBV-driven lymphoid neoplasms associated with pediatric ALL maintenance therapy

Blood (2023) 141 (7): 743–755.

https://doi.org/10.1182/blood.2022016975

Published: 2023

Includes: Supplemental data

Journal Articles

Phase 1b Trial of Subcutaneous Epcoritamab in Pediatric Patients with Relapsed or Refractory (R/R) Aggressive Mature B-Cell Neoplasms (EPCORE Peds-1)

Mitchell S. Cairo, Mark A. Rocco, John Bernard, Satya R. Siddani, Apurvasena Parikh, Brian Elliott, Birgit Burkhardt

Blood (2022) 140 (Supplement 1): 3827–3828.

https://doi.org/10.1182/blood-2022-157546

Published: 2022

Journal Articles

The Impact of Pre-Transplant Extramedullary Disease on the Outcome of Allogeneic Hematopoietic Cell Transplantation for Acute Myeloid Leukemia in Children- on Behalf of PDWP/EBMT

Blood (2022) 140 (Supplement 1): 12938–12940.

https://doi.org/10.1182/blood-2022-162484

Published: 2022

Journal Articles

Outcomes of Allogeneic Hematopoietic Stem Cell Transplantation for Congenital Amegakaryocytic Thrombocytopenia, a PDWP/EBMT Study

Blood (2022) 140 (Supplement 1): 10895–10896.

https://doi.org/10.1182/blood-2022-166636

Published: 2022

Journal Articles

Hypersensitivity Reactions to Native E. coli L-Asparaginase in Children with Acute Lymphoblastic Leukemia May Vary By Treatment Schedule and Type of Glucocorticoid in Induction: Results of Trial ALL-BFM 2000

Blood (2022) 140 (Supplement 1): 11676–11678.

https://doi.org/10.1182/blood-2022-163142

Published: 2022

Journal Articles

Integrative genomic analysis of pediatric T-cell lymphoblastic lymphoma reveals candidates of clinical significance

Blood (2021) 137 (17): 2347–2359.

https://doi.org/10.1182/blood.2020005381

Published: 2021

Includes: Supplemental data

Journal Articles

Progressive or relapsed Burkitt lymphoma or leukemia in children and adolescents after BFM-type first-line therapy

Wilhelm Woessmann, Martin Zimmermann, Andrea Meinhardt, Stephanie Müller, Holger Hauch, Fabian Knörr, Ilske Oschlies, Wolfram Klapper, Felix Niggli, Edita Kabickova, Andishe Attarbaschi, Alfred Reiter, Birgit Burkhardt

Blood (2020) 135 (14): 1124–1132.

https://doi.org/10.1182/blood.2019003591

Published: 2020

Includes: Supplemental data

Journal Articles

The mutational landscape of Burkitt-like lymphoma with 11q aberration is distinct from that of Burkitt lymphoma

Blood (2019) 133 (9): 962–966.

https://doi.org/10.1182/blood-2018-07-864025

Published: 2019

Includes: Supplemental data

Journal Articles

Prospective Clinical Phase II Results on Treosulfan-Based Conditioning Treatment of 70 Paediatric Patients with Haematological Malignancies

Blood (2018) 132 (Supplement 1): 3354.

https://doi.org/10.1182/blood-2018-99-110980

Published: 2018

Journal Articles

Stem Cell Transplantation for Pediatric Patients with Non-Anaplastic Peripheral T-Cell Lymphoma on Behalf of the EBMT-Pediatric Diseases Working Party

Olga Moser, MD, Arnaud Dalissier, PhD, Eric Beohou, Wilhelm Woessmann, MD, Birgit Burkhardt, MD PhD, Karin Mellgren, MD PhD, Peter Bader, MD PhD, Andre Manfred Willasch, MD, Udo Kontny, MD

Blood (2018) 132 (Supplement 1): 5787.

https://doi.org/10.1182/blood-2018-99-116809

Published: 2018

Journal Articles

IG- MYC + neoplasms with precursor B-cell phenotype are molecularly distinct from Burkitt lymphomas

Blood (2018) 132 (21): 2280–2285.

https://doi.org/10.1182/blood-2018-03-842088

Published: 2018

Includes: Supplemental data

Journal Articles

Clinical Heterogeneity in RUNX1-Associated Familial Myelodysplastic Syndrome - Report of Two Novel Pedigrees with Childhoodleukemia

Tim Ripperger, Birgit Burkhardt, PhD MD, Fabian Hauck, MD PhD, Michael H. Albert, MD, Kathrin Thomay, Dr. rer. nat., Marcin Wlodarski, MD, Ayami Yoshimi, MD, Gudrun Göhring, MD, Brigitte Schlegelberger, Prof, MD, Charlotte M Niemeyer, Prof, MD, Doris Steinemann, Prof

Blood (2016) 128 (22): 5509.

https://doi.org/10.1182/blood.V128.22.5509.5509

Published: 2016

Journal Articles

The minimum required level of donor chimerism in hereditary hemophagocytic lymphohistiocytosis

Blood (2016) 127 (25): 3281–3290.

https://doi.org/10.1182/blood-2015-12-684498

Published: 2016

Includes: Supplemental data

Journal Articles

Identification of Blut, a Novel Long-Noncoding RNA Differentially Expressed in Burkitt Lymphoma

Blood (2015) 126 (23): 3875.

https://doi.org/10.1182/blood.V126.23.3875.3875

Published: 2015

Journal Articles

New Insights into Potential Driver Mutations in Pediatric Burkitt Lymphoma

Marius Rohde, Martin Zimmermann, Bettina R. Bonn, Monika Szczepanowski, Ilske Oschlies, Wolfram Klapper, MD, Anja Möricke, Martin Schrappe, Inga Nagel, Reiner Siebert, Alfred Reiter, MD, Birgit Burkhardt

Blood (2014) 124 (21): 2980.

https://doi.org/10.1182/blood.V124.21.2980.2980

Published: 2014

Journal Articles

Relapsed or Refractory Burkitt Lymphoma in Children and Adolescents after BFM-Type First-Line Therapy - a BFM Group Report

Wilhelm Woessmann, MD, Martin Zimmermann, Birgit Burkhardt, Andrea Meinhardt, MD, Christine Rosenbusch, MD, Vera Vaillant, MD, Ilske Oschlies, Wolfram Klapper, MD, Felix Niggli, MD, Andishe Attarbaschi, MD, Georg Mann, MD, Martin Schrappe, MD, Alfred Reiter, MD

Blood (2014) 124 (21): 1738.

https://doi.org/10.1182/blood.V124.21.1738.1738

Published: 2014

Journal Articles

Proposal of a Genetic Classifier for Risk Group Stratification in Pediatric T-Cell Lymphoblastic Lymphoma Reveals Significant Differences to T-Cell Lymphoblastic Leukemia

Bettina R. Bonn, Martin Zimmermann, PhD, Sebastian Balbach, Marius Rohde, Ilske Oschlies, Wolfram Klapper, MD, Olga Makarova, Claudia Rossig, MD, Birgit Burkhardt

Blood (2014) 124 (21): 2398.

https://doi.org/10.1182/blood.V124.21.2398.2398

Published: 2014

NARROW

Pediatric T-cell lymphoblastic lymphomas but not leukemias harbor TRB :: NOTCH1 fusions with unfavorable outcome

Mutational and transcriptional landscape of pediatric B-cell precursor lymphoblastic lymphoma

A Phase I/II Trial to Evaluate the Safety, Pharmacokinetics, and Efficacy of Glofitamab As Monotherapy and in Combination with R-ICE Chemoimmunotherapy in Children and Young Adults with Relapsed/Refractory B-Cell Non-Hodgkin Lymphoma (iMATRIX-GLO)

EBV-driven lymphoid neoplasms associated with pediatric ALL maintenance therapy

Phase 1b Trial of Subcutaneous Epcoritamab in Pediatric Patients with Relapsed or Refractory (R/R) Aggressive Mature B-Cell Neoplasms (EPCORE Peds-1)

The Impact of Pre-Transplant Extramedullary Disease on the Outcome of Allogeneic Hematopoietic Cell Transplantation for Acute Myeloid Leukemia in Children- on Behalf of PDWP/EBMT

Outcomes of Allogeneic Hematopoietic Stem Cell Transplantation for Congenital Amegakaryocytic Thrombocytopenia, a PDWP/EBMT Study

Hypersensitivity Reactions to Native E. coli L-Asparaginase in Children with Acute Lymphoblastic Leukemia May Vary By Treatment Schedule and Type of Glucocorticoid in Induction: Results of Trial ALL-BFM 2000

Integrative genomic analysis of pediatric T-cell lymphoblastic lymphoma reveals candidates of clinical significance

Progressive or relapsed Burkitt lymphoma or leukemia in children and adolescents after BFM-type first-line therapy

The mutational landscape of Burkitt-like lymphoma with 11q aberration is distinct from that of Burkitt lymphoma

Prospective Clinical Phase II Results on Treosulfan-Based Conditioning Treatment of 70 Paediatric Patients with Haematological Malignancies

Stem Cell Transplantation for Pediatric Patients with Non-Anaplastic Peripheral T-Cell Lymphoma on Behalf of the EBMT-Pediatric Diseases Working Party

IG- MYC + neoplasms with precursor B-cell phenotype are molecularly distinct from Burkitt lymphomas

Clinical Heterogeneity in RUNX1-Associated Familial Myelodysplastic Syndrome - Report of Two Novel Pedigrees with Childhoodleukemia

The minimum required level of donor chimerism in hereditary hemophagocytic lymphohistiocytosis

Identification of Blut, a Novel Long-Noncoding RNA Differentially Expressed in Burkitt Lymphoma

New Insights into Potential Driver Mutations in Pediatric Burkitt Lymphoma

Relapsed or Refractory Burkitt Lymphoma in Children and Adolescents after BFM-Type First-Line Therapy - a BFM Group Report

Proposal of a Genetic Classifier for Risk Group Stratification in Pediatric T-Cell Lymphoblastic Lymphoma Reveals Significant Differences to T-Cell Lymphoblastic Leukemia

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only